That is where levocarnitine enters the picture
and the potential launch or commercialization of any of the Companys product candidates or products and our strategic and product development objectives and goals, and the other factors discussed under the caption Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the Securities and Exchange Commission on November 12, 2025 and in our other filings with the SEC
Before the development and synthesis of these peptides, research into tissue regeneration and skin remodeling relied largely on isolated growth factors and nonspecific biochemical agents
Sudden diarrhea usually occurs when your body is adjusting to a new, higher dosage phase
In addition, preclinical and clinical data were used to study the potential effects of drugs with multiple agonists and pathways through which gut-brain signaling pathways can be used to promote sustained weight loss without side effects